These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 4564720)
21. A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety. Kasich AM Curr Ther Res Clin Exp; 1968 Oct; 10(10):508-13. PubMed ID: 4971465 [No Abstract] [Full Text] [Related]
23. [Controlled clinical study of the action of mebeverine hydrochloride in the treatment of irritable colon]. Secco GB; Di Somma C; Arnulfo G; Ricci C Minerva Med; 1983 Mar; 74(13):699-702. PubMed ID: 6339996 [TBL] [Abstract][Full Text] [Related]
25. [Multicenter study on the effectiveness and tolerance of a bromazepam + propantheline combination in patients with irritable bowel syndrome]. Dioguardi N; Agape D; Antoniozzi F; Ballarin E; De Franchis R; Ferrari A; Fesce E; Grimoldi D; Pozzi M; Psilogenis M Minerva Dietol Gastroenterol; 1987; 33(2):155-67. PubMed ID: 2888056 [No Abstract] [Full Text] [Related]
26. [Asa foetida in the treatment of the irritable colon: a double-blind trial (author's transl)]. Rahlfs VW; Mössinger P Dtsch Med Wochenschr; 1979 Jan; 104(4):140-3. PubMed ID: 365493 [TBL] [Abstract][Full Text] [Related]
27. [A multicenter controlled trial of a combination of kaolin, sterculia gum, meprobamate, and magnesium salts, in the irritable bowel syndrome (author's transl)]. Capron JP; Zeitoun P; Julien D Gastroenterol Clin Biol; 1981 Jan; 5(1):67-72. PubMed ID: 7009302 [No Abstract] [Full Text] [Related]
30. Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy. Greenbaum DS Psychopharmacol Bull; 1984; 20(4):622-8. PubMed ID: 6149598 [No Abstract] [Full Text] [Related]
31. [The irritable colon]. Bansky G Schweiz Med Wochenschr; 1982 Feb; 112(9):314-9. PubMed ID: 7079714 [TBL] [Abstract][Full Text] [Related]
32. [Effect of a buzepide metiodide-haloperidol combination in treating functional intestinal disorders. Randomized double-blind controlled versus placebo study]. Barbier JP; Dorf G; Gordin J; Krainik F; Neveu D; Parlier H; Richard P; Vitaux J; Fraitag B Ann Gastroenterol Hepatol (Paris); 1989 May; 25(3):123-8. PubMed ID: 2672998 [TBL] [Abstract][Full Text] [Related]
33. Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome. Arthurs Y; Fielding JF Ir Med J; 1983 May; 76(5):253. PubMed ID: 6307924 [No Abstract] [Full Text] [Related]
34. A controlled replication of the effectiveness of diphenylhydantoin in reducing irritability and anxiety in selected neurotic outpatients. Stephens JH; Shaffer JW J Clin Pharmacol; 1973; 13(8):351-6. PubMed ID: 4579971 [No Abstract] [Full Text] [Related]
35. Diphenylhydantoin control of alcohol withdrawal seizures. Results of a controlled study. Sampliner R; Iber FL JAMA; 1974 Dec; 230(10):1430-2. PubMed ID: 4610196 [No Abstract] [Full Text] [Related]
36. The elusive irritable-bowel syndrome. N Engl J Med; 1973 Apr; 288(15):796-7. PubMed ID: 4694771 [No Abstract] [Full Text] [Related]
37. Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Lancaster-Smith MJ; Prout BJ; Pinto T; Anderson JA; Schiff AA Acta Psychiatr Scand; 1982 Jul; 66(1):33-41. PubMed ID: 7124431 [TBL] [Abstract][Full Text] [Related]
38. The irritable bowel syndrome. Ford MJ J Psychosom Res; 1986; 30(4):399-410. PubMed ID: 3020239 [TBL] [Abstract][Full Text] [Related]
39. Diphenylhydantoin and phenobarbital in the relief of psychoneurotic symptoms. A controlled comparison. Uhlenhuth EH; Stephens JH; Dim BH; Covi L Psychopharmacologia; 1972; 27(1):67-84. PubMed ID: 4562952 [No Abstract] [Full Text] [Related]